nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—NGF—Parkinson's disease	0.657	0.838	CbGaD
Clenbuterol—TNF—Parkinson's disease	0.127	0.162	CbGaD
Clenbuterol—NGF—superior cervical ganglion—Parkinson's disease	0.0269	0.275	CbGeAlD
Clenbuterol—NGF—adrenal medulla—Parkinson's disease	0.0221	0.226	CbGeAlD
Clenbuterol—NGF—sympathetic nervous system—Parkinson's disease	0.0147	0.15	CbGeAlD
Clenbuterol—NGF—autonomic nervous system—Parkinson's disease	0.00987	0.101	CbGeAlD
Clenbuterol—NGF—peripheral nervous system—Parkinson's disease	0.00712	0.0728	CbGeAlD
Clenbuterol—NGF—nerve—Parkinson's disease	0.00555	0.0568	CbGeAlD
Clenbuterol—NGF—forebrain—Parkinson's disease	0.0023	0.0235	CbGeAlD
Clenbuterol—NGF—spinal cord—Parkinson's disease	0.00148	0.0152	CbGeAlD
Clenbuterol—NGF—head—Parkinson's disease	0.00132	0.0135	CbGeAlD
Clenbuterol—NGF—nervous system—Parkinson's disease	0.00125	0.0128	CbGeAlD
Clenbuterol—NGF—central nervous system—Parkinson's disease	0.0012	0.0123	CbGeAlD
Clenbuterol—NGF—brain—Parkinson's disease	0.000955	0.00976	CbGeAlD
Clenbuterol—ADRB1—forebrain—Parkinson's disease	0.000599	0.00612	CbGeAlD
Clenbuterol—ADRB1—cardiovascular system—Parkinson's disease	0.000507	0.00518	CbGeAlD
Clenbuterol—ADRB1—head—Parkinson's disease	0.000343	0.00351	CbGeAlD
Clenbuterol—ADRB1—nervous system—Parkinson's disease	0.000325	0.00332	CbGeAlD
Clenbuterol—ADRB1—central nervous system—Parkinson's disease	0.000313	0.0032	CbGeAlD
Clenbuterol—ADRB1—brain—Parkinson's disease	0.000249	0.00254	CbGeAlD
Clenbuterol—CYP1A1—head—Parkinson's disease	0.000221	0.00226	CbGeAlD
Clenbuterol—CYP1A1—nervous system—Parkinson's disease	0.00021	0.00214	CbGeAlD
Clenbuterol—CYP1A1—central nervous system—Parkinson's disease	0.000202	0.00206	CbGeAlD
Clenbuterol—CYP1A1—brain—Parkinson's disease	0.00016	0.00164	CbGeAlD
Clenbuterol—ADRB2—GPCR downstream signaling—PDYN—Parkinson's disease	3.53e-05	0.000299	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—HTR7—Parkinson's disease	3.53e-05	0.000299	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—DRD2—Parkinson's disease	3.53e-05	0.000299	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PENK—Parkinson's disease	3.51e-05	0.000297	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—IL6—Parkinson's disease	3.44e-05	0.000291	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	3.41e-05	0.000288	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	3.41e-05	0.000288	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—ABL1—Parkinson's disease	3.37e-05	0.000285	CbGpPWpGaD
Clenbuterol—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	3.36e-05	0.000284	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—GRM5—Parkinson's disease	3.36e-05	0.000284	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	3.34e-05	0.000282	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—ADRBK1—Parkinson's disease	3.31e-05	0.00028	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—DGKQ—Parkinson's disease	3.29e-05	0.000278	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GPR37—Parkinson's disease	3.29e-05	0.000278	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	3.28e-05	0.000278	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PDYN—Parkinson's disease	3.28e-05	0.000277	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PDYN—Parkinson's disease	3.26e-05	0.000276	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	3.26e-05	0.000276	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	3.21e-05	0.000272	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	3.21e-05	0.000272	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	3.21e-05	0.000271	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HTR7—Parkinson's disease	3.21e-05	0.000271	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—DRD2—Parkinson's disease	3.21e-05	0.000271	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	3.11e-05	0.000263	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—GFAP—Parkinson's disease	3.07e-05	0.00026	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IGF2—Parkinson's disease	3.07e-05	0.000259	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IL6—Parkinson's disease	3.06e-05	0.000259	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—GRM5—Parkinson's disease	3.05e-05	0.000258	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	3.05e-05	0.000258	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—GRM5—Parkinson's disease	3.03e-05	0.000257	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PPP1R1B—Parkinson's disease	3.01e-05	0.000254	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	2.98e-05	0.000252	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—EDN1—Parkinson's disease	2.97e-05	0.000251	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IGF1R—Parkinson's disease	2.97e-05	0.000251	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	2.94e-05	0.000249	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—EDN1—Parkinson's disease	2.93e-05	0.000248	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	2.9e-05	0.000246	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—MCCC1—Parkinson's disease	2.87e-05	0.000243	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ND3—Parkinson's disease	2.87e-05	0.000243	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—ADORA2A—Parkinson's disease	2.85e-05	0.000241	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—IL6—Parkinson's disease	2.83e-05	0.00024	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—EDN1—Parkinson's disease	2.83e-05	0.000239	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—COMT—Parkinson's disease	2.82e-05	0.000239	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	2.82e-05	0.000239	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	2.82e-05	0.000239	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	2.81e-05	0.000238	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	2.8e-05	0.000237	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	2.79e-05	0.000236	CbGpPWpGaD
Clenbuterol—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	2.78e-05	0.000235	CbGpPWpGaD
Clenbuterol—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	2.77e-05	0.000234	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—TALDO1—Parkinson's disease	2.7e-05	0.000228	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—OMD—Parkinson's disease	2.7e-05	0.000228	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—IL6—Parkinson's disease	2.69e-05	0.000227	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FGF20—Parkinson's disease	2.66e-05	0.000225	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RIT2—Parkinson's disease	2.63e-05	0.000222	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—HTR2A—Parkinson's disease	2.6e-05	0.00022	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—ADORA2A—Parkinson's disease	2.59e-05	0.000219	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	2.58e-05	0.000218	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ADORA2A—Parkinson's disease	2.58e-05	0.000218	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	2.57e-05	0.000217	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—EDN1—Parkinson's disease	2.57e-05	0.000217	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HTR2A—Parkinson's disease	2.56e-05	0.000217	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NDUFB11—Parkinson's disease	2.56e-05	0.000216	CbGpPWpGaD
Clenbuterol—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	2.55e-05	0.000215	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	2.54e-05	0.000215	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	2.54e-05	0.000215	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GRK5—Parkinson's disease	2.49e-05	0.000211	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—HTR1A—Parkinson's disease	2.48e-05	0.00021	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—HTR2A—Parkinson's disease	2.47e-05	0.000209	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.45e-05	0.000207	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GCH1—Parkinson's disease	2.44e-05	0.000206	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—TAC1—Parkinson's disease	2.44e-05	0.000206	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	2.44e-05	0.000206	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	2.42e-05	0.000205	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—DRD1—Parkinson's disease	2.39e-05	0.000202	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	2.39e-05	0.000202	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—APOE—Parkinson's disease	2.38e-05	0.000202	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—INSR—Parkinson's disease	2.38e-05	0.000201	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	2.34e-05	0.000198	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—DRD3—Parkinson's disease	2.32e-05	0.000196	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	2.27e-05	0.000192	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FGB—Parkinson's disease	2.25e-05	0.00019	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HTR1A—Parkinson's disease	2.25e-05	0.00019	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HTR2A—Parkinson's disease	2.24e-05	0.00019	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HTR1A—Parkinson's disease	2.24e-05	0.000189	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GRM4—Parkinson's disease	2.23e-05	0.000189	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—INS—Parkinson's disease	2.23e-05	0.000189	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—TAC1—Parkinson's disease	2.21e-05	0.000187	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TAC1—Parkinson's disease	2.2e-05	0.000186	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.2e-05	0.000186	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	2.2e-05	0.000186	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	2.19e-05	0.000185	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GBA—Parkinson's disease	2.18e-05	0.000184	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—FBP1—Parkinson's disease	2.18e-05	0.000184	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—DBH—Parkinson's disease	2.18e-05	0.000184	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—DRD1—Parkinson's disease	2.17e-05	0.000184	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	2.17e-05	0.000183	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—ADRBK1—Parkinson's disease	2.16e-05	0.000183	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—DRD1—Parkinson's disease	2.16e-05	0.000183	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	2.12e-05	0.00018	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PENK—Parkinson's disease	2.12e-05	0.000179	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAG—Parkinson's disease	2.12e-05	0.000179	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	2.12e-05	0.000179	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—DRD3—Parkinson's disease	2.1e-05	0.000178	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—DRD2—Parkinson's disease	2.09e-05	0.000177	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—HTR7—Parkinson's disease	2.09e-05	0.000177	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—DRD3—Parkinson's disease	2.09e-05	0.000177	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PENK—Parkinson's disease	2.07e-05	0.000175	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAG—Parkinson's disease	2.07e-05	0.000175	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	2.06e-05	0.000174	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	2.05e-05	0.000173	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	2.05e-05	0.000173	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—INS—Parkinson's disease	2.04e-05	0.000172	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—ADRBK1—Parkinson's disease	1.96e-05	0.000166	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ADRBK1—Parkinson's disease	1.96e-05	0.000165	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	1.94e-05	0.000164	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PDYN—Parkinson's disease	1.94e-05	0.000164	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	1.92e-05	0.000163	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—DRD2—Parkinson's disease	1.9e-05	0.000161	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HTR7—Parkinson's disease	1.9e-05	0.000161	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	1.89e-05	0.00016	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HTR7—Parkinson's disease	1.89e-05	0.00016	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—DRD2—Parkinson's disease	1.89e-05	0.00016	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	1.86e-05	0.000157	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	1.86e-05	0.000157	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MCCC1—Parkinson's disease	1.83e-05	0.000155	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ND3—Parkinson's disease	1.83e-05	0.000155	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GFAP—Parkinson's disease	1.82e-05	0.000154	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GRM5—Parkinson's disease	1.8e-05	0.000152	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	1.78e-05	0.000151	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	1.76e-05	0.000149	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—OMD—Parkinson's disease	1.72e-05	0.000146	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—TALDO1—Parkinson's disease	1.72e-05	0.000146	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—EDN1—Parkinson's disease	1.68e-05	0.000142	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	1.64e-05	0.000139	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	1.63e-05	0.000138	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—DDC—Parkinson's disease	1.6e-05	0.000135	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IGF2—Parkinson's disease	1.59e-05	0.000134	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FGF20—Parkinson's disease	1.58e-05	0.000134	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GCH1—Parkinson's disease	1.56e-05	0.000132	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	1.54e-05	0.000131	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IGF1R—Parkinson's disease	1.53e-05	0.00013	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ADORA2A—Parkinson's disease	1.53e-05	0.00013	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—EDN1—Parkinson's disease	1.52e-05	0.000129	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EDN1—Parkinson's disease	1.52e-05	0.000128	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CASP3—Parkinson's disease	1.52e-05	0.000128	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTA4—Parkinson's disease	1.51e-05	0.000128	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	1.5e-05	0.000127	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	1.49e-05	0.000126	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.49e-05	0.000126	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—HTR2A—Parkinson's disease	1.47e-05	0.000124	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	1.44e-05	0.000121	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—INSR—Parkinson's disease	1.41e-05	0.00012	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.4e-05	0.000119	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NGF—Parkinson's disease	1.39e-05	0.000118	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MAPK8—Parkinson's disease	1.39e-05	0.000118	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GBA—Parkinson's disease	1.39e-05	0.000117	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—DBH—Parkinson's disease	1.39e-05	0.000117	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—FBP1—Parkinson's disease	1.39e-05	0.000117	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—INSR—Parkinson's disease	1.38e-05	0.000117	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PLA2G6—Parkinson's disease	1.36e-05	0.000115	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—MAOB—Parkinson's disease	1.34e-05	0.000114	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FGB—Parkinson's disease	1.34e-05	0.000113	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HTR2A—Parkinson's disease	1.33e-05	0.000113	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HTR1A—Parkinson's disease	1.33e-05	0.000112	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HTR2A—Parkinson's disease	1.33e-05	0.000112	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TAC1—Parkinson's disease	1.31e-05	0.000111	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FGB—Parkinson's disease	1.31e-05	0.000111	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	1.3e-05	0.00011	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	1.3e-05	0.00011	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—DRD1—Parkinson's disease	1.28e-05	0.000109	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	1.28e-05	0.000108	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.28e-05	0.000108	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	1.26e-05	0.000106	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—DRD3—Parkinson's disease	1.24e-05	0.000105	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—APOE—Parkinson's disease	1.23e-05	0.000104	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	1.22e-05	0.000103	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ADRBK1—Parkinson's disease	1.16e-05	9.82e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	1.14e-05	9.6e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HTR7—Parkinson's disease	1.12e-05	9.51e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—DRD2—Parkinson's disease	1.12e-05	9.51e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	1.1e-05	9.3e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	1.1e-05	9.3e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—INS—Parkinson's disease	1.05e-05	8.91e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—DDC—Parkinson's disease	1.02e-05	8.61e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP2D6—Parkinson's disease	9.99e-06	8.45e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CTGF—Parkinson's disease	9.8e-06	8.29e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—IL6—Parkinson's disease	9.74e-06	8.24e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTA4—Parkinson's disease	9.61e-06	8.13e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	9.49e-06	8.03e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	9.42e-06	7.97e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	9.21e-06	7.79e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP2E1—Parkinson's disease	9.13e-06	7.73e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	9.11e-06	7.7e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NQO1—Parkinson's disease	9.03e-06	7.64e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	9e-06	7.61e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	8.91e-06	7.54e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—TH—Parkinson's disease	8.9e-06	7.53e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL6—Parkinson's disease	8.9e-06	7.53e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	8.8e-06	7.45e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	8.66e-06	7.32e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MAOB—Parkinson's disease	8.57e-06	7.25e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYCS—Parkinson's disease	8.55e-06	7.23e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NGF—Parkinson's disease	8.27e-06	7e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	8.15e-06	6.9e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NGF—Parkinson's disease	8.09e-06	6.84e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	7.87e-06	6.66e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CASP3—Parkinson's disease	7.84e-06	6.63e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL6—Parkinson's disease	7.79e-06	6.59e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	7.7e-06	6.51e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—COMT—Parkinson's disease	7.57e-06	6.4e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTP1—Parkinson's disease	7.53e-06	6.37e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—MAOA—Parkinson's disease	7.52e-06	6.36e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—HMOX1—Parkinson's disease	7.43e-06	6.29e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APOE—Parkinson's disease	7.32e-06	6.19e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAPK8—Parkinson's disease	7.21e-06	6.1e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APOE—Parkinson's disease	7.16e-06	6.06e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ABCB1—Parkinson's disease	7.13e-06	6.03e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTM1—Parkinson's disease	6.92e-06	5.86e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GPX1—Parkinson's disease	6.63e-06	5.61e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	6.37e-06	5.39e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—INS—Parkinson's disease	6.25e-06	5.29e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CTGF—Parkinson's disease	6.25e-06	5.29e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—MTHFR—Parkinson's disease	6.12e-06	5.18e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—INS—Parkinson's disease	6.12e-06	5.17e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	5.82e-06	4.93e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NQO1—Parkinson's disease	5.76e-06	4.87e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOE—Parkinson's disease	5.7e-06	4.82e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—TH—Parkinson's disease	5.68e-06	4.8e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYCS—Parkinson's disease	5.45e-06	4.61e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—INS—Parkinson's disease	4.87e-06	4.12e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—COMT—Parkinson's disease	4.83e-06	4.08e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTP1—Parkinson's disease	4.8e-06	4.06e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MAOA—Parkinson's disease	4.79e-06	4.05e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—HMOX1—Parkinson's disease	4.74e-06	4.01e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	4.65e-06	3.94e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	4.62e-06	3.91e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL6—Parkinson's disease	4.6e-06	3.89e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	4.55e-06	3.85e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ABCB1—Parkinson's disease	4.55e-06	3.85e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	4.52e-06	3.83e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTM1—Parkinson's disease	4.41e-06	3.73e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	4.28e-06	3.62e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GPX1—Parkinson's disease	4.23e-06	3.58e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	4.18e-06	3.54e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MTHFR—Parkinson's disease	3.9e-06	3.3e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOE—Parkinson's disease	3.63e-06	3.07e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—INS—Parkinson's disease	3.1e-06	2.62e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL6—Parkinson's disease	2.73e-06	2.31e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL6—Parkinson's disease	2.67e-06	2.26e-05	CbGpPWpGaD
